Table 2.
Pathogenic or likely pathogenic variants identified in TCF4 during targeted sequencing (TES), whole exome sequencing (WES) or whole genome sequencing (WGS) in patients with intellectual disability (ID)
Cohort | Reference | Approach | Number of patients | TCF4 mutations |
---|---|---|---|---|
ID (mild to severe) | this study | TES (275–456 genes) | 903 | 8 |
ID (mild to severe) | Redin et al. [1] | TES (217 genes) | 106 | 2 |
ID (moderate to severe) | Grozeva et al. [12] | TES (575 genes) | 986 | 2 |
ID | Tan et al. [15] | TES (90 genes) | 52 | 2 |
ID (severe) | Rauch et al. [14] | WES | 51 | (1*) |
ID (moderate to severe) | de Ligt et al. [11] | WES | 100 | 1 |
ID (moderate to severe) | Hamdan et al. [13] | WES | 41 | 1 |
Total | 2239 | 16 (0.7%) |
* de novo missense variant predicted to be benign, not included in the statistics